Candel Therapeutics, Inc. (NASDAQ: CADL) reported Q1 EPS of ($0.14), $0.20 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Candel Therapeutics, Inc. (CADL) click here.